Marc-Olivier Sirard, Cpa-Ca

Investment Adviser - Venture Capital - Life sciences

📍 Montreal, Quebec, Canada🔄 Updated September 2026💼 1 investments📅 6 years investing🗓 Last invested Jul 2020
Angel investor🌍 Canada
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2020
Thryv Therapeutics Inc. (previously LQT Therapeutics Inc.) is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.
Experience · 1 entries
All (1)
Investments (1)
Board (1)
2020
Board Member
Jul 2020
Thryv Therapeutics Inc. (previously LQT Therapeutics Inc.) is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.